Citius Oncology Reports Nationwide Deployment of LYMPHIR's Broadened Commercial Organization and Expanding Market Adoption

Summary

Citius Oncology reports nationwide deployment of expanded commercial and medical affairs teams for LYMPHIR, with full U.S. operational status expected by August 2026. The expansion reflects broadened commercialization efforts and growing market adoption of the oncology product.